16 December 2010
The ICH Steering Committee has approved the development of a new ICH E2C(R2) Guideline to replace the current ICH E2C(R1) Guideline “Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs”. This work will be undertaken along with a general evaluation of ICH pharmacovigilance guidance, which will include the conduct of a gap and potential improvement analysis of ICH E2C, E2E and E2F Guidelines. The Expert Working Group which will be tasked with this work will also be charged with developing a plan for review of other ICH guidelines for presentation to the ICH Steering Committee. The development of the Concept Paper for this new work item was sponsored by the EU, with input from pharmacovigilance experts who met recently in Fukuoka to brainstorm on this topic.
Dear Dr. Tucker,
ReplyDeleteIt’s a great pleasure to read your blog. I find your post very informative. Thank you for sharing your insights.
As a reader, I consider your writing to be a great example of a quality and globally competitive output. It would be a great thrill and honor if you could share your genuine ideas and knowledge to our community, Physician Nexus. With this you can gain 1000 physician readers from over 62 countries on Nexus.
We would love for you to visit our community. It's free, takes seconds, and is designed for physicians only - completely free of industry bias and commercial interests.
Best,
Janmar Delicana
On behalf of the Physician Nexus Team
www.PhysicianNexus.com